Immunology · Year 2 · from Immunology

Case 3: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1/APECED)

Patient Demographics

  • Age: 9 years old
  • Sex: Female
  • Ethnicity: Finnish descent

Chief Complaint

Muscle cramps and recurrent oral thrush

History of Present Illness

A 9-year-old girl of Finnish descent presents with hand and foot muscle cramping and tingling for 2 weeks. She has a history of chronic oral thrush since age 3 that has been difficult to control. Her parents note that she has also developed patchy hair loss over the past year.

Past Medical History

  • Chronic mucocutaneous candidiasis since age 3 (oral, esophageal, nail involvement)
  • Alopecia areata starting at age 8
  • Dental enamel hypoplasia (noted by dentist)

Family History

  • Parents are first cousins (consanguineous)
  • No known family history of autoimmune disease

Physical Examination

  • General: Well-appearing girl
  • Vital Signs: Normal
  • HEENT: White plaques on tongue and buccal mucosa (oral candidiasis); dental enamel defects
  • Skin: Patches of alopecia on scalp (alopecia areata pattern)
  • Nails: Thickened, dystrophic fingernails (onychomycosis)
  • Neurological: Positive Chvostek sign (facial muscle twitch with tapping over facial nerve); positive Trousseau sign (carpopedal spasm with BP cuff inflation)

Laboratory Workup

TestResultReference Range
Calcium6.2 mg/dL8.5-10.5 mg/dL
Phosphorus7.5 mg/dL3.0-5.5 mg/dL
PTH8 pg/mL15-65 pg/mL
MagnesiumNormal--
Cortisol (AM)Normal--
ACTH stimulation testNormal--
Anti-IFN-omega antibodiesPositiveNegative
Anti-IL-17A antibodiesPositiveNegative
Anti-IL-22 antibodiesPositiveNegative
AIRE geneHomozygous mutationWild type

Clinical Image

Image showing chronic oral candidiasis, one of the characteristic features of APECED/APS-1. Image source: Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Oral_thrush_adult.jpg). Licensed under CC BY-SA 4.0.

Diagnosis

Autoimmune Polyendocrine Syndrome Type 1 (APS-1)/APECED (Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy) due to AIRE gene mutation.

Discussion

APS-1/APECED is caused by autosomal recessive mutations in AIRE (Autoimmune Regulator), a transcription factor critical for central T cell tolerance:

AIRE's normal function:

  • Expressed in medullary thymic epithelial cells
  • Drives expression of tissue-restricted antigens (insulin, thyroglobulin, etc.) in the thymus
  • Allows deletion of T cells reactive against these peripheral tissue antigens
  • Without AIRE, autoreactive T cells escape to the periphery

Classic diagnostic triad (2 of 3 required):

  1. Chronic mucocutaneous candidiasis (CMC) - usually first manifestation, often by age 5
  2. Hypoparathyroidism - causes hypocalcemia (present in this case)
  3. Adrenal insufficiency - often develops later

Additional manifestations:

  • Ectodermal dystrophy: Dental enamel hypoplasia, nail dystrophy
  • Alopecia areata or totalis
  • Vitiligo
  • Autoimmune hepatitis
  • Type 1 diabetes
  • Autoimmune thyroiditis
  • Pernicious anemia
  • Autoimmune ovarian/testicular failure

Why does AIRE deficiency cause candidiasis?

  • Patients develop neutralizing autoantibodies against IL-17A, IL-17F, and IL-22
  • These cytokines are essential for mucosal defense against Candida
  • The autoantibodies functionally impair Th17-mediated immunity
  • This case demonstrates positive anti-IL-17 and anti-IL-22 antibodies

Epidemiology:

  • More common in Finnish, Iranian Jewish, and Sardinian populations
  • Autosomal recessive inheritance (consanguinity is a risk factor)

Treatment

  1. Hypoparathyroidism: Calcium and calcitriol (active vitamin D) supplementation
  2. Chronic mucocutaneous candidiasis: Long-term antifungal therapy (fluconazole, itraconazole)
  3. Surveillance for additional autoimmune manifestations:
  • Annual screening for adrenal insufficiency (cortisol, ACTH)
  • Monitor for diabetes, thyroid disease, hepatitis
  1. Hormone replacement: As needed for each endocrinopathy
  2. Genetic counseling: For autosomal recessive inheritance
  3. No disease-modifying therapy available: Treatment is supportive and directed at individual manifestations

All cases for this lecture as Markdown